株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

CountryFocus:インドネシアの医療・規制・医療費償還制度の情勢

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Indonesia

発行 GlobalData 商品コード 299161
出版日 ページ情報 英文 150 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.97円で換算しております。
Back to Top
CountryFocus:インドネシアの医療・規制・医療費償還制度の情勢 CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Indonesia
出版日: 2017年09月01日 ページ情報: 英文 150 Pages
概要

当レポートでは、インドネシアの医療・規制・医療費償還制度について調査分析し、医薬品・医療機器市場の概要、医療費償還制度とその関連情報、規制当局の構造や規制の概要、国の情勢、医療インフラなどの最新情報を提供しています。

第1章 目次

第2章 イントロダクション

第3章 医薬品・医療機器市場の概要

  • 医薬品市場
  • 医療機器市場
  • 市場促進要因・障壁

第4章 市場参入

  • 医療費償還・保険料払込者の情勢
  • 規制情勢

第5章 国の分析

  • 政策環境
  • 経済情勢
  • 経済指標
  • 人口統計
  • 医療インフラ
  • 医療費
  • 産業団体
  • 見本市

第6章 機会と課題

  • 機会
  • 課題

第7章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC0058CHR

Indonesian pharmaceutical market increased from US$3.13 Billion in 2009 to US$6.20 Billion in 2016, at a Compound Annual Growth Rate (CAGR) of 10.3%. The market value is expected to reach US$10.11 Billion in 2021. The growth of the Indonesian pharmaceutical sector is largely driven by the Universal Health Coverage scheme (Jaminan Kesehatan Nasional, JKN), which prioritizes the use of generics. Despite increasing sales of unbranded generics, the sector is witnessing a growing number of new players, which drive price competition and reduce margins. In 2015, the unbranded generic market represented a 10.8% of the pharmaceutical market.

In 2015, the pharmaceutical-sales-to-GDP ratio shrank to 0.57%, despite pharmaceutical sales increasing from US$6.18 Billion in the previous year to US$6.89 Billion. Pharmaceutical sales per capita increased from US$24.5 Billion in 2014 to US$26.9 Billion in 2015. The pharmaceutical-sales-to-health-spending ratio dropped from US$21.4 Billion in 2014 to US$20.5 Billion in 2015. Non-communicable diseases cost the economy US$7 Billion between 2011 and 2015 in treatment and loss of productivity.

Medical device market of Indonesia was worth US$2.28 Billion in 2016, and is expected to reach US$2.83 Billion in 2017 and US$3.54 Billion in 2018. Indonesia manufactures hospital beds, disposable supplies and wheelchairs, but imports more than 90% of its medical devices, as the domestic industry is under-developed.

The report "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Indonesia" is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Indonesia. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Indonesia.

In particular, this report provides the following -

  • Provides an overview of the Indonesian pharmaceutical and medical device markets, covering market size; the market shares of generic, Over-the-Counter (OTC) and biologic/biosimilar products; and the key drivers and barriers for the overall market. It also includes profiles of the major players, as well as SWOT assessments.
  • Covers the reimbursement and payer landscape, and includes details of the reimbursement process, insurance providers, pricing policies and drug price trends in Indonesia. It also looks at the regulatory landscape, and gives an overview of the regulatory agencies and approval processes for new drugs and medical devices.
  • Detailed analysis of the political and economic environment in Indonesia, and analyzes economic indicators, demographics, and healthcare infrastructure and expenditure.
  • Provides an overview of the opportunities for and challenges to growth in the Indonesian healthcare market.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Indonesia, and includes -

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market (Kalbe Farma, Tempo Scan, Kimia Farma, DaryaVaria and IndoFarma)
  • An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
  • Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the Indonesian healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -

  • Develop business strategies by understanding the trends shaping and driving the Indonesian healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact the healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
  • Identify, understand, and capitalize on the opportunities and challenges in the Indoensian healthcare market.

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 5
  • 1.2 List of Figures 7

2 Executive Summary 9

3 Introduction 13

  • 3.1 GlobalData Report Guidance 13

4 Overview of the Pharmaceutical and Medical Device Markets 14

  • 4.1 Pharmaceutical Market 14
    • 4.1.1 Market Overview 14
    • 4.1.2 Pharmaceutical Imports and Exports 18
    • 4.1.3 Supply Channels 19
    • 4.1.4 Market Segments 20
    • 4.1.5 Overview Drug Classes 25
    • 4.1.6 Major Players 26
  • 4.2 Medical Device Market 42
    • 4.2.1 Market Overview 42
  • 4.3 Market Drivers and Barriers 42
    • 4.3.1 Drivers 42
    • 4.3.2 Barriers 43

5 Market Access 45

  • 5.1 Reimbursement and Payer Landscape 45
    • 5.1.1 Overview of Healthcare System 45
    • 5.1.2 Drug Classifications 47
    • 5.1.3 Drug Reimbursement Process 48
    • 5.1.4 Overview of Insurance Providers 50
    • 5.1.5 Patient Share in Healthcare Spending 54
    • 5.1.6 Price Trend in Healthcare Services 56
    • 5.1.7 Pricing Policies 56
  • 5.2 Regulatory Landscape 57
    • 5.2.1 Overview of Regulatory Agencies 57
    • 5.2.2 Market Authorization Procedure for New Drugs 59
    • 5.2.3 Market Authorization Procedure for Medical Devices 67
    • 5.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 70
    • 5.2.5 Licensing Process for Pharmaceutical Exports and Imports 71
    • 5.2.6 Intellectual Property Rights 71
    • 5.2.7 Clinical Trial Regulations 74
    • 5.2.8 Advertising Regulations 76
    • 5.2.9 Pharmacy Regulations 76
    • 5.2.10 Labeling and Packaging Regulations 76

6 Country Analysis 78

  • 6.1 Political Environment 78
    • 6.1.1 Political Structure 78
    • 6.1.2 Analysis of the Current Political Environment 79
    • 6.1.3 Healthcare Policy Initiatives 80
  • 6.2 Economic Landscape 82
  • 6.3 Economic Indicators 85
    • 6.3.1 Gross Domestic Product 85
    • 6.3.2 Gross National Income 89
    • 6.3.3 Inflation 90
    • 6.3.4 Currency Exchange Rate 92
    • 6.3.5 Foreign Direct Investment 93
    • 6.3.6 Foreign Exchange Reserves 94
    • 6.3.7 Trade Balance 95
    • 6.3.8 General Government Structural Balance 97
    • 6.3.9 General Government Gross Debt 98
    • 6.3.10 Major Industries 98
  • 6.4 Demographics 100
    • 6.4.1 Population 100
    • 6.4.2 Urban-Rural Share 102
    • 6.4.3 Distribution by Age Group 103
    • 6.4.4 Birth Rate 105
    • 6.4.5 Mortality 106
    • 6.4.6 Causes of Mortality 107
    • 6.4.7 Health Status by Gender and Age 108
    • 6.4.8 Education and Literacy 114
    • 6.4.9 Employment 116
    • 6.4.10 Disease Burden 116
  • 6.5 Healthcare Infrastructure 118
    • 6.5.1 Healthcare Facilities 118
    • 6.5.2 Healthcare Parameters 121
    • 6.5.3 Environmental Health 121
    • 6.5.4 Healthcare Personnel 124
  • 6.6 Healthcare Expenditure 127
    • 6.6.1 Overview 127
    • 6.6.2 Public-Private Sector Share 128
    • 6.6.3 Major Components of Healthcare Spending 129
  • 6.7 Trade Associations 129
    • 6.7.1 International Pharmaceutical Manufacturers Group 129
    • 6.7.2 Indonesia Pharmaceutical Association 130
    • 6.7.3 Indonesian Medical Association 130
  • 6.8 Trade Fairs 131

7 Opportunities and Challenges 132

  • 7.1 Opportunities 132
  • 7.2 Challenges 132

8 Appendix 134

  • 8.1 Abbreviations 134
  • 8.2 Bibliography 136
  • 8.3 Research Methodology 147
    • 8.3.1 Coverage 147
    • 8.3.2 Secondary Research 147
    • 8.3.3 Forecasts 148
    • 8.3.4 Expert Panel 149
  • 8.4 Contact Us 149
  • 8.5 Disclaimer 149

List of Tables

1.1 List of Tables

  • Table 1: Pharmaceutical Market, Indonesia, Revenue ($bn), 2009-2016 17
  • Table 2: Pharmaceutical Market, Indonesia, Revenue Forecast ($bn), 2017-2021 17
  • Table 3: Pharmaceutical Market, Indonesia, Pharmaceutical Exports and Imports ($bn), 2009-2016 18
  • Table 4: Pharmaceutical Market, Indonesia, Pharmaceutical Distribution (%), 2014 20
  • Table 5: Pharmaceutical Market, Indonesia, Unbranded Generics, Revenue ($m), 2009-2015 21
  • Table 6: Pharmaceutical Market, Indonesia, Unbranded Generics as Percentage of Total Pharmaceutical Market (%), 2009-2015 22
  • Table 7: Pharmaceutical Market, Indonesia, Over-the-Counter Drug Market Revenue ($bn), 2009-2015 23
  • Table 8: Pharmaceutical Market, Indonesia, Pharmaceutical Market Share (%), 2009-2015 24
  • Table 9: Pharmaceutical Market, Kalbe Farma, Indonesia, Major Products, 2016 27
  • Table 10: Pharmaceutical Market, Tempo Scan, Major Products, 2017 31
  • Table 11: Pharmaceutical Market, Darya Varia, Major Products, 2017 38
  • Table 12: Pharmaceutical Market, Indofarma, Major Products, 2017 40
  • Table 13: Market Access, Indonesia, JKN Coverage Population (million), 2017 53
  • Table 14: Market Access, Indonesia, Out-of-Pocket Expenditure as Percentage of Total Health Expenditure (%), 2009-2015 55
  • Table 15: Market Access, Indonesia, Healthcare Inflation (%), 2009-2016 56
  • Table 16: Economic Indicators, Indonesia, Gross Domestic Product per Capita ($), 2009-2016 85
  • Table 17: Economic Indicators, Indonesia, Gross Domestic Product per Capita Forecast ($), 2017-2021 86
  • Table 18: Economic Indicators, Indonesia, Gross Domestic Product Annual Growth (%), 2009-2016 87
  • Table 19: Economic Indicators, Indonesia, Gross Domestic Product Annual Growth Forecast (%), 2017-2021 88
  • Table 20: Economic Indicators, Indonesia, Gross National Income per Capita ($), 2009-2016 89
  • Table 21: Economic Indicators, Indonesia, Average Consumer Price Index, 2009-2016 90
  • Table 22: Economic Indicators, Indonesia, Average Consumer Price Annual Change (%), 2009-2016 91
  • Table 23: Economic Indicators, Indonesia, Currency Exchange Rate (IDR per $), 2009-2016 92
  • Table 24: Economic Indicators, Indonesia, Foreign Direct Investment ($bn), 2009-2016 93
  • Table 25: Economic Indicators, Indonesia, Foreign Exchange Reserves ($bn), 2009-2016 94
  • Table 26: Economic Indicators, Indonesia, Imports of Goods and Services ($bn), 2009-2016 95
  • Table 27: Economic Indicators, Indonesia, Exports of Goods and Services ($bn), 2009-2016 96
  • Table 28: Economic Indicators, Indonesia, Government Structural Balance ($bn), 2009-2016 97
  • Table 29: Economic Indicators, Indonesia, General Government Gross Debt ($bn), 2009-2016 98
  • Table 30: Economic Indicators, Indonesia, Major Industries by Gross Value Added (percentage of GDP), 2016 99
  • Table 31: Demographics, Indonesia, Population (million), 2009-2016 100
  • Table 32: Demographics, Indonesia, Population (million), 2017-2021 101
  • Table 33: Demographics, Indonesia, Urban-Rural Population Share (%), 2009-2016 102
  • Table 34: Demographics, Indonesia, Population Distribution by Age Group (%), 2009-2016 103
  • Table 35: Demographics, Indonesia, Population Distribution by Age Group Forecast (%), 2017-2021 104
  • Table 36: Demographics, Indonesia, Births (per 1,000 population), 2009-2016 105
  • Table 37: Demographics, Indonesia, Mortality (per 1,000 population), 2009-2015 106
  • Table 38: Demographics, Indonesia, Major Causes of Mortality ('000), 2015 107
  • Table 39: Demographics, Indonesia, Infant Mortality (per 1,000 live births), 2009-2016 108
  • Table 40: Demographics, Indonesia, Immunization Rate (%), 2009-2016 109
  • Table 41: Demographics, Indonesia, Major Causes of Male Mortality ('000), 2015 110
  • Table 42: Demographics, Indonesia, Major Causes of Female Mortality ('000), 2015 111
  • Table 43: Demographics, Indonesia, Gender Ratio (M/F), 2009-2015 112
  • Table 44: Demographics, Indonesia, Life Expectancy at Birth (years), 2009-2016 113
  • Table 45: Demographics, Indonesia, Illiteracy by Age Group (%), 2009-2016 114
  • Table 46: Demographics, Indonesia, School Enrollment by Age Group (%), 2015 115
  • Table 47: Demographics, Indonesia, Unemployment Rate (%), 2009-2016 116
  • Table 48: Demographics, Indonesia, Disability-Adjusted Life Years by Major Disease ('000), 2015 117
  • Table 49: Healthcare Infrastructure, Indonesia, Public and Private Hospitals, 2009-2016 118
  • Table 50: Healthcare Infrastructure, Indonesia, Health Centers (per 30,000 population), 2009-2016 119
  • Table 51: Healthcare Infrastructure, Indonesia, Share of Hospitals by Type of Care, 2015 120
  • Table 52: Healthcare Infrastructure, Indonesia, General Hospital Beds (per 1,000 population), 2009-2016 121
  • Table 53: Healthcare Infrastructure, Indonesia, PM2.5 (µg per m3), 2009-2015 122
  • Table 54: Healthcare Infrastructure, Indonesia, CO2 Emissions (million metric tons), 2009-2015 123
  • Table 55: Healthcare Infrastructure, Indonesia, Physicians (per 100,000 population), 2009-2015 124
  • Table 56: Healthcare Infrastructure, Indonesia, Dentists (per 100,000 population), 2009-2015 125
  • Table 57: Healthcare Infrastructure, Indonesia, Nurses (per 100,000 population), 2009-2015 126
  • Table 58: Healthcare Expenditure, Indonesia, Healthcare Expenditure as Percentage of GDP (%), 2009-2015 127
  • Table 59: Healthcare Expenditure, Indonesia, Public-Private Share (%), 2009-2015 128
  • Table 60: Healthcare Expenditure, Indonesia, Major Components of Healthcare Spending (%), 2015 129
  • Table 61: Healthcare Expenditure, Indonesia, Major Healthcare Trade Fairs, 2017 131

List of Figures

1.2 List of Figures

  • Figure 1: Pharmaceutical Market, Indonesia, Revenue ($bn), 2009-2021 10
  • Figure 2: Country Profile, Indonesia, 2017 12
  • Figure 3: Pharmaceutical Market, Indonesia, Revenue ($bn), 2009-2016 16
  • Figure 4: Pharmaceutical Market, Indonesia, Revenue Forecast ($bn), 2017-2021 17
  • Figure 5: Pharmaceutical Market, Indonesia, Pharmaceutical Exports and Imports ($bn), 2009-2016 18
  • Figure 6: Pharmaceutical Market, Indonesia, Distribution Chain, 2014 19
  • Figure 7: Pharmaceutical Market, Indonesia, Pharmaceutical Distribution (%), 2014 20
  • Figure 8: Pharmaceutical Market, Indonesia, Unbranded Generics, Revenue ($m), 2009-2015 21
  • Figure 9: Pharmaceutical Market, Indonesia, Unbranded Generics as Percentage of Total Pharmaceutical Market (%), 2009-2015 22
  • Figure 10: Pharmaceutical Market, Indonesia, Over-the-Counter Drug Market Revenue ($bn), 2009-2015 23
  • Figure 11: Pharmaceutical Market, Indonesia, Pharmaceutical Market Share (%), 2009-2015 24
  • Figure 12: Pharmaceutical Market, Indonesia, Drivers and Barriers, 2017 44
  • Figure 13: Market Access, Indonesia, Healthcare System, 2017 46
  • Figure 14: Market Access, Indonesia, History of Health Insurance System, 2017 47
  • Figure 15: Market Access, Indonesia, Process for Addition to Hospital Drug Formulary, 2015 49
  • Figure 16: Market Access, Indonesia, Registration Procedure for JKN, 2017 51
  • Figure 17: Market Access, Indonesia, Members of the JKN, 2017 52
  • Figure 18: Market Access, Indonesia, Contributions to BPJS, 2017 53
  • Figure 19: Market Access, Indonesia, Out-of-Pocket Expenditure as Percentage of Total Health Expenditure (%), 2009-2015 55
  • Figure 20: Market Access, Indonesia, Healthcare Inflation (%), 2009-2016 56
  • Figure 21: Market Access, Indonesia, Structure of the National Agency of Drug and Food Control, 2017 58
  • Figure 22: Market Access, Indonesia, New Drug Application Procedure, 2017 60
  • Figure 23: Market Access, Indonesia, Drug Registration Procedure, 2017 62
  • Figure 24: Market Access, Indonesia, Drug Evaluation and Decision Making Pathway, 2017 64
  • Figure 25: Market Access, Indonesia, Regulatory Framework on Ensuring Quality, Safety and Efficacy of Medicine, 2017 65
  • Figure 26: Market Access, Indonesia, Policy for Biosimilar Product Evaluation, 2017 66
  • Figure 27: Market Access, Indonesia, General Guidelines on Evaluation of Biosimilar Products, 2017 66
  • Figure 28: Market Access, Indonesia, Registration of Biosimilar Products, 2017 67
  • Figure 29: Market Access, Indonesia, Medical Device Approval Process, 2017 70
  • Figure 30: Market Access, Indonesia, Licensing Process for Manufacturing, 2017 71
  • Figure 31: Market Access, Indonesia, Structure of the Directorate General of Intellectual Property Office, 2017 72
  • Figure 32: Market Access, Indonesia, Patent Approval Process, 2017 73
  • Figure 33: Market Access, Indonesia, Clinical Trial Regulation Process, 2017 75
  • Figure 34: Economic Indicators, Indonesia, Gross Domestic Product per Capita ($), 2009-2016 85
  • Figure 35: Economic Indicators, Indonesia, Gross Domestic Product per Capita Forecast ($), 2017-2021 86
  • Figure 36: Economic Indicators, Indonesia, Gross Domestic Product Annual Growth (%), 2009-2016 87
  • Figure 37: Economic Indicators, Indonesia, Gross Domestic Product Annual Growth Forecast (%), 2017-2021 88
  • Figure 38: Economic Indicators, Indonesia, Gross National Income per Capita ($), 2009-2016 89
  • Figure 39: Economic Indicators, Indonesia, Average Consumer Price Index, 2009-2016 90
  • Figure 40: Economic Indicators, Indonesia, Average Consumer Price Annual Change (%), 2009-2016 91
  • Figure 41: Economic Indicators, Indonesia, Currency Exchange Rate (IDR per $), 2009-2016 92
  • Figure 42: Economic Indicators, Indonesia, Foreign Direct Investment ($bn), 2009-2016 93
  • Figure 43: Economic Indicators, Indonesia, Foreign Exchange Reserves ($bn), 2009-2016 94
  • Figure 44: Economic Indicators, Indonesia, Imports of Goods and Services ($bn), 2009-2016 95
  • Figure 45: Economic Indicators, Indonesia, Exports of Goods and Services ($bn), 2009-2016 96
  • Figure 46: Economic Indicators, Indonesia, Government Structural Balance ($bn), 2009-2016 97
  • Figure 47: Economic Indicators, Indonesia, General Government Gross Debt ($bn), 2009-2016 98
  • Figure 48: Economic Indicators, Indonesia, Major Industries by Gross Value Added (percentage of GDP), 2016 99
  • Figure 49: Demographics, Indonesia, Population (million), 2009-2016 100
  • Figure 50: Demographics, Indonesia, Population (million), 2017-2021 101
  • Figure 51: Demographics, Indonesia, Urban-Rural Population Share (%), 2009-2016 102
  • Figure 52: Demographics, Indonesia, Population Distribution by Age Group (%), 2009-2016 103
  • Figure 53: Demographics, Indonesia, Population Distribution by Age Group Forecast (%), 2017-2021 104
  • Figure 54: Demographics, Indonesia, Births (per 1,000 population), 2009-2016 105
  • Figure 55: Demographics, Indonesia, Mortality (per 1,000 population), 2009-2015 106
  • Figure 56: Demographics, Indonesia, Major Causes of Mortality ('000), 2015 107
  • Figure 57: Demographics, Indonesia, Infant Mortality (per 1,000 live births), 2009-2016 108
  • Figure 58: Demographics, Indonesia, Immunization Rate (%), 2009-2016 109
  • Figure 59: Demographics, Indonesia, Major Causes of Male Mortality ('000), 2015 110
  • Figure 60: Demographics, Indonesia, Major Causes of Female Mortality ('000), 2015 111
  • Figure 61: Demographics, Indonesia, Gender Ratio (M/F), 2009-2015 112
  • Figure 62: Demographics, Indonesia, Life Expectancy at Birth (years), 2009-2016 113
  • Figure 63: Demographics, Indonesia, Illiteracy by Age Group (%), 2009-2016 114
  • Figure 64: Demographics, Indonesia, School Enrollment by Age Group (%), 2015 115
  • Figure 65: Demographics, Indonesia, Unemployment Rate (%), 2009-2016 116
  • Figure 66: Demographics, Indonesia, Disability-Adjusted Life Years by Major Disease ('000), 2015 117
  • Figure 67: Healthcare Infrastructure, Indonesia, Public and Private Hospitals, 2009-2016 118
  • Figure 68: Healthcare Infrastructure, Indonesia, Health Centers (per 30,000 population), 2009-2016 119
  • Figure 69: Healthcare Infrastructure, Indonesia, Health Centers (per 100,000 population), 2009-2016 120
  • Figure 70: Healthcare Infrastructure, Indonesia, General Hospital Beds (per 1,000 population), 2009-2016 121
  • Figure 71: Healthcare Infrastructure, Indonesia, PM2.5 (µg per m3), 2009-2015 122
  • Figure 72: Healthcare Infrastructure, Indonesia, CO2 Emissions (million metric tons), 2009-2015 123
  • Figure 73: Healthcare Infrastructure, Indonesia, Physicians (per 100,000 population), 2009-2015 124
  • Figure 74: Healthcare Infrastructure, Indonesia, Dentists (per 100,000 population), 2009-2015 125
  • Figure 75: Healthcare Infrastructure, Indonesia, Nurses (per 100,000 population), 2009-2015 126
  • Figure 76: Healthcare Expenditure, Indonesia, Healthcare Expenditure as Percentage of GDP (%), 2009-2015 127
  • Figure 77: Healthcare Expenditure, Indonesia, Public-Private Share (%), 2009-2015 128
  • Figure 78: Healthcare Expenditure, Indonesia, Major Components of Healthcare Spending (%), 2015 129
  • Figure 79: Healthcare Market, Indonesia, Opportunities and Challenges, 2017 133
Back to Top